SCHEMBL2365665

SCHEMBL2365665

CN1CCc2ccc(-c3cccc(Cl)c3)cc2CC1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 7/20 0.47
DRD3 P35462 7/20 0.47
DRD1 P21728 4/20 0.47
DRD5 P21918 4/20 0.47
DRD4 P21917 2/20 0.47
HTR6 P50406 4/20 0.46
HTR2C P28335 3/20 0.46
CYP2D6 P10635 2/20 0.46
CYP3A4 P08684 2/20 0.46
HTR2A P28223 2/20 0.46
CYP1A2 P05177 1/20 0.46
CYP2C9 P11712 1/20 0.46
CYP2C19 P33261 1/20 0.46
PARP10 Q53GL7 1/20 0.46
PARP11 Q9NR21 1/20 0.46
TDP2 O95551 1/20 0.46
ADRA2A P08913 1/20 0.45
ADRA2B P18089 1/20 0.45
ADRA2C P18825 1/20 0.45
ADRA1D P25100 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL160943 0.80 HTR2A (0.55) DRD2DRD3DRD1DRD5DRD4
SCHEMBL4321862 0.76 MAOA (0.60) DRD2DRD3DRD1DRD5DRD4
SCHEMBL6883015 0.75 MAOA (0.59) DRD2DRD3DRD1DRD5DRD4
SCHEMBL29991420 0.73 MAOA (0.55) DRD2DRD3DRD1DRD5DRD4
SCHEMBL2625798 0.73 MAOA (0.55) DRD2DRD3DRD1DRD5DRD4
SCHEMBL11558057 0.72 QDPR (0.56) HTR6HTR2C
SCHEMBL20079881 0.71 CYP11B1 (0.52) CYP3A4CYP1A2CYP2C9CYP2C19PARP10
SCHEMBL4139998 0.71 HRH3 (0.45) PARP10PARP11TDP2
SCHEMBL16394285 0.71 TAAR1 (0.71) CYP1A2TDP2PGRESR2ALOX5
SCHEMBL31491189 0.71 TAAR1 (0.71) CYP1A2TDP2PGRESR2ALOX5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2363394-A1 8-Chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine, its salts, solvates or hydrates and its use for the treatment of CNS disorders Arena Pharmaceuticals, Inc. (US) 2011-09-07 EP disclosed